Results pending
Imatinib: reduce relapses and new lesions in relapsing MS
relapsing MS · Microglia / innate immunity in the CNS
Trials have finished, but some results have not been read yet. There is no verdict until they are, because one unread trial can change the answer.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
No controlled trial has reported a result yet.
Other linked trials: 1
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 1
These linked trials do not set the status.
- Imatinib MSNo result found
Phase 2 · 2018 · Compared with methylprednisolone
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-28Trials: 2 → 1
- 2026-10-27First listed as Results pending
Related hypotheses
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error